Novozymes A/S (NVZMY) Expected to Announce Earnings on Thursday

Novozymes A/S (OTCMKTS:NVZMY) is projected to post its results before the market opens on Thursday, November 5th. Analysts expect Novozymes A/S to post earnings of $0.7430 per share and revenue of $1.28 billion for the quarter.

Novozymes A/S (OTCMKTS:NVZMY) last released its quarterly earnings data on Thursday, August 20th. The biotechnology company reported $0.44 EPS for the quarter, missing the consensus estimate of $0.60 by ($0.16). The company had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Novozymes A/S had a return on equity of 6.54% and a net margin of 14.70%. On average, analysts expect Novozymes A/S to post $2.45 EPS for the current fiscal year and $2.64 EPS for the next fiscal year.

Novozymes A/S Trading Down 1.4%

Shares of NVZMY stock opened at $68.34 on Wednesday. The stock has a market capitalization of $28.33 billion, a PE ratio of 38.94, a P/E/G ratio of 3.11 and a beta of 0.86. Novozymes A/S has a 1-year low of $49.90 and a 1-year high of $75.27. The business has a 50-day moving average of $67.57 and a 200 day moving average of $62.59. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.74 and a quick ratio of 1.04.

Novozymes A/S Company Profile

Novozymes A/S was a Denmark-based biotechnology company that developed and commercialized enzymes, microorganisms and other biological solutions for industrial and consumer applications. Its products were designed to help customers improve manufacturing processes, reduce resource consumption and develop more sustainable alternatives to conventional chemicals and production methods.

The company served a broad range of industries, including food and beverages, household care, agriculture, animal health, bioenergy and industrial manufacturing.